Cargando…
Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
l‐Type amino acid transporter 1 (LAT1) disulfide linked to CD98 heavy chain (hc) is highly expressed in most cancer cells, but weakly expressed in normal cells. In the present study, we developed novel anti‐LAT1 mAbs and showed internalization activity, inhibitory effects of amino acid uptake and ce...
Autores principales: | Ueda, Shiho, Hayashi, Hidemi, Miyamoto, Takako, Abe, Shinya, Hirai, Kana, Matsukura, Kanji, Yagi, Hideki, Hara, Yuta, Yoshida, Kinji, Okazaki, Shogo, Tamura, Masakazu, Abe, Yuki, Agatsuma, Toshinori, Niwa, Shin‐ichiro, Masuko, Kazue, Masuko, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361610/ https://www.ncbi.nlm.nih.gov/pubmed/30548114 http://dx.doi.org/10.1111/cas.13908 |
Ejemplares similares
-
Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
por: Ikotun, Oluwatayo F., et al.
Publicado: (2013) -
Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021) -
Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016) -
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene
por: Okita, Kouki, et al.
Publicado: (2020) -
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)